{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:18:59Z","timestamp":1773497939564,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ijrobp.2011.11.069","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T19:23:58Z","timestamp":1340393038000},"page":"456-463","source":"Crossref","is-referenced-by-count":80,"title":["Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung"],"prefix":"10.1016","volume":"84","author":[{"given":"Mohan","family":"Suntharalingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Krasna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak","family":"Choy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.11.069_bib1","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","article-title":"Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications","volume":"18","author":"Andre","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00000658-198309000-00015","article-title":"Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases","volume":"198","author":"Martini","year":"1983","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM199010043231403","article-title":"A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer","volume":"323","author":"Dillman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib4","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000421-199710000-00002","article-title":"Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06","volume":"20","author":"Komaki","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","article-title":"Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer","volume":"87","author":"Sause","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib8","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805","volume":"13","author":"Albain","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-5223(95)70278-4","article-title":"Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group","volume":"109","author":"Sugarbaker","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0003-4975(00)01585-X","article-title":"Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival","volume":"70","author":"Bueno","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib11","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.2005.03.008","article-title":"Multimodality therapy for stage III non-small-cell lung cancer","volume":"23","author":"Farray","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0003-4975(99)00593-7","article-title":"Safe pulmonary resection after chemotherapy and high-dose thoracic radiation","volume":"68","author":"Sonett","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.athoracsur.2004.04.085","article-title":"Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer","volume":"78","author":"Sonett","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.athoracsur.2008.06.022","article-title":"Phase I\/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer","volume":"86","author":"Edelman","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2011.11.069_bib18","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","article-title":"Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial","volume":"21","author":"Betticher","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611036273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611036273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T11:21:08Z","timestamp":1542885668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611036273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0360301611036273"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.11.069","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}